Recent Research
A recent study calls into question whether lower rates of lung cancer diagnosis in higher BMI patients holds true for African Americans.
Jefferson soared in the latest U.S. News & World Report 2022-2023 Best Colleges list released Sept. 12. The University ranked No. 127 among National Universities, up from No. 148 last year and No. 176 two years ago.
New findings shed further light on how the coronavirus affects pregnant women and add evidence for safety and protection of vaccines.
Connecting patients with the natural world through design.
How Nursing Research Improves Patient Care and Recovery.
Thomas Jefferson University and Jefferson Health’s Board of Trustees have announced that Joseph G. Cacchione, MD, will join as the organization’s new CEO, effective September 6, 2022.
New research shows that the majority of gene changes in the brain caused by lead can be reversed by raising animals in stimulating environments.
As part of its planning for a new senior executive operating model, the Thomas Jefferson University Board of Trustees has appointed Mark L. Tykocinski, MD, as the next President of Thomas Jefferson University, effective July 1, 2022.
New research in mice from Thomas Jefferson University has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.
For news not listed on this page view the Jefferson News Archive.